Stock markets
-
Business
Netflix stock surges 16% after Wall Street buys into ad-driven subscriber growth
[ad_1] A picture of a woman starting Netflix on a TV inside her apartment. Artur Widak | NurPhoto | Getty…
Read More » -
Health News
Pfizer gets upgrade at Jefferies, which says there’s a buying opportunity in the pharma giant’s stock
[ad_1] Jefferies thinks it’s time for investors to go long on Pfizer . The firm upgraded the pharmaceutical stock to…
Read More » -
Business
Op-ed: Investors must be patient and should plan for the likelihood that the worst is yet to come
[ad_1] The floor of the New York Stock Exchange. Spencer Platt | Getty Images August and September are historically the…
Read More » -
Pics News
JPMorgan says this packaged food company can rally 25% thanks to strong cash flow
[ad_1] Post Holdings is “a post-er child for strong free cash flow,” according to JPMorgan. Analyst Ken Goldman initiated coverage…
Read More » -
Pics News
The CPI trade: Here’s where JPMorgan sees the market going, based on these scenarios
[ad_1] Investors are closely anticipating September’s consumer price index report on Thursday for insight into the state of inflation as…
Read More » -
Health News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
[ad_1] Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success…
Read More » -
Business
ChargePoint shares fall after EV charging operator announces $232 million raise
[ad_1] A ChargePoint electric vehicle charging station at Walnut Creek City Hall parking lot, Walnut Creek, California, April 18, 2023.…
Read More » -
Pics News
These stocks are looking mighty cheap going into earnings season
[ad_1] The third-quarter earnings season is set to kick off this week – with certain stocks trading at attractive valuations.…
Read More » -
Pics News
These defensive stocks could help investors fortify their portfolio in this risky market
[ad_1] The unexpected Israel-Hamas conflict is the latest risk to what was already an unstable market environment — but there…
Read More » -
Health News
JPMorgan says controversial eye disease treatment can more than double this biopharma stock
[ad_1] A controversial eye treatment from Apellis can lead to sharp returns for investors, according to JPMorgan. The bank upgraded…
Read More »